Transform Your Portfolio With This Simple Morning Trade!

Hi, I’m trading expert Dave Aquino and I want to show you how to take advantage of a trading opportunity happening nearly every morning at 9:30 EST.

My free guide, “How To Master The Retirement Trade” will show you exactly why traders in the know want to keep this trade a secret.

ADPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,648,599.14

Adaptive Biotechnologies Insider Trading History Chart

Adaptive Biotechnologies Share Price & Price History

^$5.07

▼ -0.11 (-2.12%)

As of 09/22/2023 01:00 AM ET

Days: 30 | 90 | 365

How He’s Maintained A Staggering 6-Year 97% Trading Win Rate

From Investing Daily | Ad

Economic Downturns, Pandemics, Wars—Nothing Shakes His Portfolio. He's Had Unearthly Wins In Both Bull And Bear Markets.

For Close To A Decade, He’s Maintained A Staggering 97% Trading Win Rate. He Didn't Follow The Wall Street Playbook, And Still Became A Millionaire Trader By The Age Of 37!

Watch His Exclusive Tell-All Interview Here Now

Adaptive Biotechnologies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/7/2023	Nitin Sood	Insider	Sell	5,652	$6.78	$38,320.56	225,358
6/20/2023	Tycho Peterson	CFO	Sell	134,961	$8.14	$1,098,582.54	399,219
6/15/2023	Tycho Peterson	CFO	Sell	70,000	$8.53	$597,100.00	399,219
6/2/2023	Tycho Peterson	CFO	Sell	38,000	$7.16	$272,080.00	454,891
4/10/2023	R. Mark Adams	COO	Sell	817	$8.50	$6,944.50	177,669
3/27/2023	Michelle Renee Griffin	Director	Sell	2,341	$8.49	$19,875.09	20,627
3/6/2023	Julie Rubinstein	President	Sell	22,668	$8.57	$194,264.76	336,824
3/6/2023	Kyle Piskel	Insider	Sell	3,529	$8.57	$30,243.53	87,564
3/6/2023	R. Mark Adams	COO	Sell	6,529	$8.57	$55,953.53	195,641
3/6/2023	Stacy L. Taylor	SVP	Sell	5,491	$8.57	$47,057.87	153,065
1/9/2023	R. Mark Adams	COO	Sell	995	$8.50	$8,457.50	115,648
11/16/2022	Kyle Piskel	Insider	Sell	959	$8.87	$8,506.33	46,706
11/1/2022	Nitin Sood	Insider	Sell	31,066	$8.00	$248,528.00	114,505
10/10/2022	R. Mark Adams	COO	Sell	2,284	$7.13	$16,284.92	116,643
10/7/2022	R. Mark Adams	COO	Sell	841	$7.61	$6,400.01	118,927
8/5/2022	Nitin Sood	Insider	Sell	17,540	$10.98	$192,589.20	145,571
7/7/2022	R. Mark Adams	COO	Sell	825	$9.53	$7,862.25	122,068
4/7/2022	R. Mark Adams	COO	Sell	831	$13.17	$10,944.27	122,893
3/9/2022	Chad M Robins	CEO	Sell	14,815	$12.46	$184,594.90
3/7/2022	Chad M Robins	CEO	Sell	4,424	$12.01	$53,132.24
3/7/2022	Julie Rubinstein	President	Sell	4,613	$12.01	$55,402.13
3/7/2022	Lance Baldo	Insider	Sell	2,373	$12.01	$28,499.73
3/7/2022	R. Mark Adams	COO	Sell	1,244	$12.01	$14,940.44
3/7/2022	Stacy L. Taylor	SVP	Sell	1,569	$12.01	$18,843.69
12/22/2021	Chad M. Cohen	CFO	Sell	10,000	$30.00	$300,000.00
12/22/2021	Stacy L. Taylor	SVP	Sell	15,338	$30.00	$460,140.00
11/18/2021	Harlan S. Robins	Insider	Sell	300	$31.36	$9,408.00
11/9/2021	Chad M. Cohen	CFO	Sell	5,000	$36.03	$180,150.00
10/21/2021	Harlan S. Robins	Insider	Sell	3,700	$33.73	$124,801.00
10/19/2021	Harlan S. Robins	Insider	Sell	3,800	$33.69	$128,022.00
10/8/2021	Harlan S. Robins	Insider	Sell	3,895	$32.96	$128,379.20
10/7/2021	R. Mark Adams	COO	Sell	1,324	$32.47	$42,990.28
10/6/2021	Chad M. Cohen	CFO	Sell	5,000	$32.30	$161,500.00
10/6/2021	Harlan S. Robins	Insider	Sell	3,895	$32.27	$125,691.65
9/14/2021	Harlan S. Robins	Insider	Sell	3,895	$36.74	$143,102.30	73,255
9/10/2021	Chad M Robins	CEO	Sell	5,000	$38.38	$191,900.00	1,705,218
9/8/2021	Chad M Robins	CEO	Sell	13,746	$38.45	$528,533.70
9/7/2021	Chad M. Cohen	CFO	Sell	9,375	$39.71	$372,281.25	30,979
9/7/2021	Stacy L. Taylor	SVP	Sell	495	$40.00	$19,800.00
8/27/2021	Harlan S. Robins	Insider	Sell	3,895	$34.78	$135,468.10	73,255
8/27/2021	Michelle Renee Griffin	Director	Sell	14,916	$35.00	$522,060.00	16,420
8/25/2021	Harlan S. Robins	Insider	Sell	3,895	$34.09	$132,780.55
8/10/2021	Chad M. Cohen	CFO	Sell	5,000	$35.00	$175,000.00	26,604
7/21/2021	Harlan S. Robins	Insider	Sell	3,895	$37.82	$147,308.90	73,255
7/19/2021	Harlan S. Robins	Insider	Sell	3,895	$37.12	$144,582.40	73,255
7/19/2021	Jyoti Palaniappan	SVP	Sell	651	$36.12	$23,514.12	9,809
7/14/2021	Michelle Renee Griffin	Director	Sell	2,500	$36.80	$92,000.00
7/12/2021	Chad M. Robins	CEO	Sell	1,501	$38.24	$57,398.24	1,716,960
7/7/2021	Chad M. Cohen	CFO	Sell	10,000	$38.53	$385,300.00	31,604
7/7/2021	R. Mark Adams	COO	Sell	871	$39.42	$34,334.82
6/30/2021	Stacy L. Taylor	SVP	Sell	4,167	$41.42	$172,597.14
6/17/2021	Chad M Robins	CEO	Sell	5,255	$39.53	$207,730.15	1,729,361
6/17/2021	Michelle Renee Griffin	Director	Sell	4,000	$40.00	$160,000.00	5,504
6/17/2021	R. Mark Adams	COO	Sell	14,583	$40.00	$583,320.00	72,687
6/17/2021	Stacy L. Taylor	SVP	Sell	4,166	$40.00	$166,640.00	16,077
6/15/2021	Chad M. Robins	CEO	Sell	20,000	$38.27	$765,400.00	1,729,361
6/14/2021	Michelle Renee Griffin	Director	Sell	2,500	$38.56	$96,400.00	4,004
6/14/2021	R. Mark Adams	COO	Sell	8,914	$38.77	$345,595.78	58,104
6/11/2021	Harlan S. Robins	Insider	Sell	3,895	$38.41	$149,606.95	73,255
6/9/2021	Harlan S. Robins	Insider	Sell	3,895	$35.99	$140,181.05	73,255
6/8/2021	Chad M. Cohen	CFO	Sell	10,000	$37.05	$370,500.00	31,604
5/18/2021	Jyoti Palaniappan	SVP	Sell	651	$35.00	$22,785.00	9,809
5/18/2021	Michelle Renee Griffin	Director	Sell	2,500	$35.00	$87,500.00	4,004
5/14/2021	Francis Lo	Insider	Sell	2,000	$33.80	$67,600.00	22,604
5/12/2021	Chad M. Cohen	CFO	Sell	10,000	$32.63	$326,300.00	31,604
5/6/2021	Harlan S. Robins	Insider	Sell	3,895	$35.70	$139,051.50	73,255
5/4/2021	Harlan S. Robins	Insider	Sell	3,895	$36.14	$140,765.30	73,255
4/30/2021	Stacy L. Taylor	SVP	Sell	4,166	$41.93	$174,680.38	16,078
4/22/2021	Harlan S. Robins	Insider	Sell	7,790	$43.18	$336,372.20	81,045
4/20/2021	Harlan S. Robins	Insider	Sell	11,685	$40.52	$473,476.20	81,045
4/19/2021	Jyoti Palaniappan	SVP	Sell	1,301	$41.25	$53,666.25	10,459
4/15/2021	Francis Lo	Insider	Sell	2,000	$43.04	$86,080.00	22,604
4/14/2021	Michelle Renee Griffin	Director	Sell	4,500	$43.41	$195,345.00	6,004
4/8/2021	Chad M Robins	CEO	Sell	5,000	$42.45	$212,250.00	1,761,861
4/7/2021	R. Mark Adams	COO	Sell	3,586	$42.34	$151,831.24	67,018
4/6/2021	Chad M. Cohen	CFO	Sell	10,000	$40.95	$409,500.00	31,604
4/6/2021	Chad M Robins	CEO	Sell	5,000	$42.18	$210,900.00	1,761,861
3/31/2021	Stacy L. Taylor	SVP	Sell	4,167	$40.00	$166,680.00	16,078
3/25/2021	Harlan S. Robins	Insider	Sell	5,290	$38.30	$202,607.00	77,150
3/23/2021	Harlan S. Robins	Insider	Sell	7,790	$41.93	$326,634.70	77,150
3/19/2021	Chad M Robins	CEO	Sell	5,000	$41.97	$209,850.00	1,776,560
3/18/2021	Jyoti Palaniappan	SVP	Sell	16,052	$43.58	$699,546.16	25,210
3/17/2021	Chad M Robins	CEO	Sell	5,000	$44.16	$220,800.00	1,776,560
3/15/2021	Michelle Renee Griffin	Director	Sell	4,500	$41.75	$187,875.00	6,004
3/15/2021	Sharon Benzeno	Insider	Sell	1,354	$41.69	$56,448.26	24,248
3/10/2021	David E. Goel	Director	Sell	56,000	$41.96	$2,349,760.00
3/9/2021	Chad M. Cohen	CFO	Sell	10,000	$40.24	$402,400.00	31,064
3/8/2021	David E. Goel	Director	Sell	500,000	$39.50	$19,750,000.00	3,504
2/26/2021	Julie Rubinstein	President	Sell	15,000	$56.23	$843,450.00	15,000
2/26/2021	Stacy L. Taylor	SVP	Sell	2,812	$55.53	$156,150.36	2,341
2/22/2021	Julie Rubinstein	President	Sell	15,000	$59.71	$895,650.00	15,000
2/18/2021	Julie Rubinstein	President	Sell	15,000	$60.92	$913,800.00	15,000
2/16/2021	Francis Lo	Insider	Sell	2,000	$65.45	$130,900.00	2,000
2/16/2021	Julie Rubinstein	President	Sell	15,000	$65.25	$978,750.00	15,000
2/16/2021	Michelle Renee Griffin	Director	Sell	6,000	$65.08	$390,480.00	1,504
2/16/2021	Stacy L. Taylor	SVP	Sell	16,250	$64.64	$1,050,400.00	17,550
2/11/2021	Julie Rubinstein	President	Sell	15,000	$63.28	$949,200.00	15,000
2/10/2021	Chad M Robins	CEO	Sell	10,000	$62.76	$627,600.00	1,732,466
2/9/2021	Julie Rubinstein	President	Sell	15,000	$62.41	$936,150.00	15,000
2/8/2021	Chad M Robins	CEO	Sell	10,000	$61.61	$616,100.00	1,732,466
2/4/2021	Julie Rubinstein	President	Sell	15,000	$58.98	$884,700.00	15,000
2/3/2021	Harlan S. Robins	Insider	Sell	7,790	$59.58	$464,128.20	8,469
2/1/2021	Harlan S. Robins	Insider	Sell	7,790	$55.83	$434,915.70	8,469
2/1/2021	Julie Rubinstein	President	Sell	15,000	$55.54	$833,100.00	15,000
1/29/2021	Julie Rubinstein	President	Sell	15,000	$56.28	$844,200.00	15,000
1/29/2021	Stacy L. Taylor	SVP	Sell	2,813	$56.51	$158,962.63	2,342
1/28/2021	Chad M. Cohen	CFO	Sell	50,000	$56.22	$2,811,000.00	51,000
1/28/2021	Chad M Robins	CEO	Sell	10,000	$56.91	$569,100.00	1,765,930
1/27/2021	Julie Rubinstein	President	Sell	15,000	$58.94	$884,100.00	15,000
1/27/2021	Lance Baldo	Insider	Sell	40,000	$58.95	$2,358,000.00	40,000
1/26/2021	Chad M Robins	CEO	Sell	10,000	$63.53	$635,300.00	1,765,930
1/25/2021	Chad M. Cohen	CFO	Sell	50,000	$66.07	$3,303,500.00	51,000
1/25/2021	Julie Rubinstein	President	Sell	15,000	$66.43	$996,450.00	15,000
1/22/2021	Julie Rubinstein	President	Sell	15,000	$66.84	$1,002,600.00	15,000
1/21/2021	Harlan S. Robins	Insider	Sell	23,370	$66.82	$1,561,583.40	24,049
1/20/2021	Julie Rubinstein	President	Sell	15,000	$67.59	$1,013,850.00	15,000
1/19/2021	Chad M. Cohen	CFO	Sell	50,000	$68.61	$3,430,500.00	51,000
1/19/2021	Chad M Robins	CEO	Sell	8,400	$70.43	$591,612.00	1,769,880
1/19/2021	Nancy Louise Hill	EVP	Sell	25,000	$69.00	$1,725,000.00	12,000
1/19/2021	Sharon Benzeno	Insider	Sell	417	$69.00	$28,773.00	417
1/15/2021	Francis Lo	Insider	Sell	2,000	$66.55	$133,100.00	2,000
1/14/2021	Julie Rubinstein	President	Sell	15,000	$65.62	$984,300.00	15,000
1/14/2021	Michelle Renee Griffin	Director	Sell	6,000	$65.88	$395,280.00	6,000
1/12/2021	Chad M. Cohen	CFO	Sell	75,000	$62.59	$4,694,250.00	76,000
1/12/2021	Julie Rubinstein	President	Sell	15,000	$62.69	$940,350.00	15,000
1/8/2021	Julie Rubinstein	President	Sell	8,814	$60.46	$532,894.44	15,000
1/6/2021	Julie Rubinstein	President	Sell	15,000	$54.89	$823,350.00	15,000
1/4/2021	Eric Dobmeier	Director	Sell	10,000	$57.34	$573,400.00	10,000
1/4/2021	Julie Rubinstein	President	Sell	15,000	$57.17	$857,550.00	15,000
1/4/2021	Sharon Benzeno	Insider	Sell	6,771	$57.39	$388,587.69	2,604
12/31/2020	Stacy L. Taylor	SVP	Sell	6,530	$57.86	$377,825.80
12/30/2020	Julie Rubinstein	President	Sell	15,000	$59.61	$894,150.00	15,000
12/29/2020	Chad M Robins	CEO	Sell	16,790	$59.28	$995,311.20	1,794,430
12/28/2020	Julie Rubinstein	President	Sell	15,000	$61.58	$923,700.00	15,000
12/24/2020	Julie Rubinstein	President	Sell	15,000	$63.53	$952,950.00	15,000
12/22/2020	Julie Rubinstein	President	Sell	15,000	$63.71	$955,650.00	15,000
12/22/2020	Nancy Louise Hill	EVP	Sell	57,000	$63.71	$3,631,470.00	67,000
12/21/2020	Michael J Pellini	Director	Sell	25,000	$60.00	$1,500,000.00	25,000
12/21/2020	Sharon Benzeno	Insider	Sell	417	$59.14	$24,661.38	417
12/15/2020	Robert Hershberg	Director	Sell	2,000	$55.93	$111,860.00	2,000
12/14/2020	Global Investors Lp Viking	Major Shareholder	Sell	1,000,000	$55.65	$55,650,000.00
12/14/2020	Nancy Louise Hill	EVP	Sell	40,000	$59.00	$2,360,000.00	50,000
12/11/2020	Charles Sang	SVP	Sell	50,000	$56.13	$2,806,500.00	25,000
12/8/2020	Chad M. Cohen	CFO	Sell	30,000	$51.24	$1,537,200.00	31,000
12/7/2020	Lance Baldo	Insider	Sell	6,250	$50.41	$315,062.50	6,250
12/1/2020	Sharon Benzeno	Insider	Sell	6,770	$48.87	$330,849.90	2,604
11/23/2020	Stacy L. Taylor	SVP	Sell	2,880	$46.31	$133,372.80	2,409
11/19/2020	Chad M Robins	CEO	Sell	16,680	$46.57	$776,787.60	1,794,860
11/19/2020	Sharon Benzeno	Insider	Sell	416	$48.86	$20,325.76	416
11/17/2020	Chad M Robins	CEO	Sell	16,680	$46.12	$769,281.60	1,794,860
11/16/2020	Francis Lo	Insider	Sell	2,000	$47.68	$95,360.00	2,000
11/16/2020	Michelle Renee Griffin	Director	Sell	6,000	$47.69	$286,140.00	6,000
11/11/2020	Global Investors Lp Viking	Major Shareholder	Sell	2,500,000	$49.52	$123,800,000.00
11/9/2020	Chad M. Cohen	CFO	Sell	30,000	$49.16	$1,474,800.00	31,000
11/6/2020	Harlan S. Robins	Insider	Sell	33,300	$50.70	$1,688,310.00	11,779
11/4/2020	Harlan S. Robins	Insider	Sell	11,100	$50.29	$558,219.00	11,779
11/2/2020	Sharon Benzeno	Insider	Sell	6,772	$45.58	$308,667.76	2,605
10/26/2020	Stacy L. Taylor	SVP	Sell	2,880	$49.78	$143,366.40	2,410
10/19/2020	Sharon Benzeno	Insider	Sell	417	$51.25	$21,371.25	417
10/15/2020	Harlan S. Robins	Insider	Sell	11,100	$51.55	$572,205.00	11,779
10/15/2020	Robert Hershberg	Director	Sell	2,000	$51.51	$103,020.00	2,000
10/12/2020	Francis Lo	Insider	Sell	25,000	$52.80	$1,320,000.00	25,000
10/8/2020	Chad M. Cohen	CFO	Sell	30,000	$50.65	$1,519,500.00	31,000
10/8/2020	Chad M Robins	CEO	Sell	24,260	$50.61	$1,227,798.60	1,796,460
10/6/2020	Chad M Robins	CEO	Sell	18,280	$49.36	$902,300.80	1,796,460
10/6/2020	Lance Baldo	Insider	Sell	6,250	$49.20	$307,500.00	6,250
10/1/2020	Chad M Robins	CEO	Sell	2,500	$50.15	$125,375.00	1,780,080
10/1/2020	Eric Dobmeier	Director	Sell	10,000	$48.53	$485,300.00	10,000
10/1/2020	Julie Rubinstein	President	Sell	94,725	$49.00	$4,641,525.00	80,000
10/1/2020	Sharon Benzeno	Insider	Sell	6,771	$48.57	$328,867.47	2,604
9/29/2020	Chad M Robins	CEO	Sell	1,900	$50.18	$95,342.00	1,780,080
9/29/2020	Julie Rubinstein	President	Sell	80,000	$49.00	$3,920,000.00	80,000
9/29/2020	Lance Baldo	Insider	Sell	25,000	$50.00	$1,250,000.00	25,000
9/29/2020	Susan Bobulsky	SVP	Sell	10,000	$50.00	$500,000.00	10,000
9/24/2020	Stacy L. Taylor	SVP	Sell	2,880	$47.78	$137,606.40	2,409

Laser breakthrough could send stock soaring 2,467%

From Behind the Markets | Ad

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

Here's the next stock we think soars >>>

SEC Filings (Institutional Ownership Changes) for Adaptive Biotechnologies (NASDAQ:ADPT)

94.31% of Adaptive Biotechnologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adaptive Biotechnologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Barclays PLC	124,909	$0.84M	0.0%	-38.3%	0.086%
9/7/2023	Triatomic Management LP	121,166	$0.81M	0.8%	+4.0%	0.084%
8/22/2023	Virginia Retirement Systems ET AL	20,400	$0.14M	0.0%	N/A	0.014%
8/21/2023	California State Teachers Retirement System	125,990	$0.85M	0.0%	-2.6%	0.087%
8/21/2023	Osaic Holdings Inc.	18,342	$0.12M	0.0%	-64.6%	0.013%
8/18/2023	Legato Capital Management LLC	100,037	$0.67M	0.1%	+39.6%	0.069%
8/15/2023	Wells Fargo & Company MN	49,817	$0.33M	0.0%	+49.7%	0.034%
8/15/2023	Y Intercept Hong Kong Ltd	18,310	$0.12M	0.0%	-32.5%	0.013%
8/15/2023	Goldman Sachs Group Inc.	2,149,230	$14.42M	0.0%	+43.3%	1.486%
8/15/2023	Royal Bank of Canada	14,689	$98K	0.0%	+62.4%	0.010%
8/15/2023	Rockefeller Capital Management L.P.	153,081	$0.96M	0.0%	-7.2%	0.106%
8/15/2023	Sherbrooke Park Advisers LLC	14,405	$97K	0.1%	N/A	0.010%
8/14/2023	PDT Partners LLC	126,343	$0.85M	0.1%	+17.4%	0.087%
8/14/2023	Tower Research Capital LLC TRC	13,395	$90K	0.0%	-65.6%	0.009%
8/14/2023	State Street Corp	2,544,628	$17.07M	0.0%	-0.9%	1.759%
8/14/2023	Caption Management LLC	18,200	$0.12M	0.0%	N/A	0.013%
8/14/2023	Aristotle Atlantic Partners LLC	3,104,961	$20.83M	0.8%	+62.8%	2.147%
8/14/2023	Jefferies Financial Group Inc.	42,500	$0.29M	0.0%	N/A	0.029%
8/14/2023	Nuveen Asset Management LLC	746,583	$5.01M	0.0%	-39.1%	0.516%
8/14/2023	Thrivent Financial for Lutherans	42,435	$0.29M	0.0%	-4.7%	0.029%
8/14/2023	Cerity Partners LLC	211,241	$1.42M	0.0%	-3.9%	0.146%
8/14/2023	Prelude Capital Management LLC	31,804	$0.21M	0.0%	-10.3%	0.022%
8/11/2023	Robertson Stephens Wealth Management LLC	199,786	$1.34M	0.1%	-1.4%	0.138%
8/11/2023	Renaissance Technologies LLC	338,500	$2.27M	0.0%	-14.1%	0.234%
8/11/2023	Westwood Holdings Group Inc.	14,520	$97K	0.0%	-70.0%	0.010%
8/11/2023	Credit Suisse AG	132,734	$0.89M	0.0%	+8.3%	0.092%
8/11/2023	BlackRock Inc.	11,482,587	$77.05M	0.0%	-2.4%	7.938%
8/11/2023	The Manufacturers Life Insurance Company	105,614	$0.71M	0.0%	-12.0%	0.073%
8/11/2023	Hsbc Holdings PLC	25,222	$0.17M	0.0%	-47.3%	0.017%
8/11/2023	Franklin Resources Inc.	35,492	$0.24M	0.0%	+85.8%	0.025%
8/11/2023	Guggenheim Capital LLC	26,446	$0.18M	0.0%	+137.4%	0.018%
8/11/2023	Geode Capital Management LLC	2,286,626	$15.34M	0.0%	+3.2%	1.581%
8/11/2023	Sei Investments Co.	44,408	$0.30M	0.0%	-5.2%	0.031%
8/11/2023	D.A. Davidson & CO.	83,275	$0.56M	0.0%	+55.0%	0.058%
8/11/2023	JPMorgan Chase & Co.	311,196	$2.09M	0.0%	-40.6%	0.215%
8/11/2023	PNC Financial Services Group Inc.	8,432	$57K	0.0%	+23.2%	0.006%
8/11/2023	Northern Trust Corp	1,049,057	$7.04M	0.0%	+1.6%	0.725%
8/11/2023	ExodusPoint Capital Management LP	140,272	$0.94M	0.0%	+397.3%	0.097%
8/10/2023	Osaic Holdings Inc.	18,342	$0.12M	0.0%	-64.6%	0.013%
8/10/2023	Great West Life Assurance Co. Can	55,805	$0.38M	0.0%	+67.0%	0.039%
8/10/2023	Commonwealth Equity Services LLC	51,766	$0.35M	0.0%	+3.6%	0.036%
8/10/2023	Charles Schwab Investment Management Inc.	837,890	$5.62M	0.0%	+1.8%	0.579%
8/10/2023	Citigroup Inc.	44,413	$0.30M	0.0%	+340.7%	0.031%
8/9/2023	Dimensional Fund Advisors LP	2,149,946	$14.43M	0.0%	+30.4%	1.486%
8/9/2023	BNP Paribas Arbitrage SNC	29,807	$0.20M	0.0%	-54.5%	0.021%
8/9/2023	TD Asset Management Inc	64,985	$0.44M	0.0%	-9.1%	0.045%
8/9/2023	Swiss National Bank	218,300	$1.47M	0.0%	+1.1%	0.151%
8/8/2023	Rhumbline Advisers	157,250	$1.06M	0.0%	-11.8%	0.109%
8/7/2023	Principal Financial Group Inc.	1,255,123	$8.42M	0.0%	+0.6%	0.868%
8/7/2023	Versor Investments LP	20,343	$0.14M	0.0%	-68.9%	0.014%
8/4/2023	Envestnet Asset Management Inc.	23,182	$0.16M	0.0%	-7.5%	0.016%
8/3/2023	Headlands Technologies LLC	9,532	$64K	0.0%	N/A	0.007%
8/3/2023	Barclays PLC	124,909	$0.84M	0.0%	-38.3%	0.087%
8/3/2023	Jennison Associates LLC	155,792	$1.05M	0.0%	+2.2%	0.108%
8/3/2023	CWM LLC	167,929	$1.13M	0.0%	-4.0%	0.116%
8/3/2023	Bank of New York Mellon Corp	373,583	$2.51M	0.0%	-2.0%	0.259%
7/31/2023	LPL Financial LLC	56,979	$0.38M	0.0%	+10.2%	0.039%
7/31/2023	Strs Ohio	83,700	$0.56M	0.0%	+3.3%	0.058%
7/31/2023	Sumitomo Mitsui Trust Holdings Inc.	6,384,047	$42.84M	0.0%	+19.9%	4.424%
7/27/2023	Virtu Financial LLC	13,840	$93K	0.0%	N/A	0.010%
7/25/2023	Olympiad Research LP	31,699	$0.21M	0.2%	-16.1%	0.022%
7/25/2023	Assenagon Asset Management S.A.	46,475	$0.31M	0.0%	+74.3%	0.032%
7/21/2023	Creative Planning	28,529	$0.19M	0.0%	+34.4%	0.020%
7/10/2023	ARK Investment Management LLC	10,453,752	$70.15M	0.5%	+13.6%	7.244%
7/10/2023	SG Americas Securities LLC	40,062	$0.27M	0.0%	-47.9%	0.028%
7/7/2023	Nordea Investment Management AB	383,779	$2.66M	0.0%	-26.3%	0.266%
6/1/2023	Prelude Capital Management LLC	35,454	$0.31M	0.0%	+56.3%	0.025%
6/1/2023	Macquarie Group Ltd.	87,531	$0.77M	0.0%	+51.2%	0.061%
5/26/2023	ProShare Advisors LLC	23,051	$0.20M	0.0%	-11.9%	0.016%
5/25/2023	Legato Capital Management LLC	71,683	$0.63M	0.1%	N/A	0.050%
5/22/2023	Putnam Investments LLC	201,316	$1.78M	0.0%	-4.1%	0.140%
5/22/2023	Ameriprise Financial Inc.	427,964	$3.78M	0.0%	+16.0%	0.297%
5/18/2023	JPMorgan Chase & Co.	523,748	$4.63M	0.0%	+29.8%	0.363%
5/18/2023	New York State Common Retirement Fund	56,086	$0.50M	0.0%	-28.5%	0.039%
5/17/2023	Rockefeller Capital Management L.P.	164,954	$1.46M	0.0%	-1.0%	0.114%
5/17/2023	Thrivent Financial for Lutherans	44,517	$0.39M	0.0%	-84.8%	0.031%
5/16/2023	Jane Street Group LLC	37,989	$0.34M	0.0%	-44.8%	0.026%
5/16/2023	State Street Corp	2,568,042	$22.67M	0.0%	+2.7%	1.780%
5/16/2023	Geode Capital Management LLC	2,215,980	$19.57M	0.0%	+3.3%	1.536%
5/16/2023	Gilder Gagnon Howe & Co. LLC	1,169,520	$10.33M	0.2%	N/A	0.810%
5/16/2023	AQR Capital Management LLC	41,623	$0.36M	0.0%	-40.9%	0.029%
5/16/2023	Aristotle Atlantic Partners LLC	1,907,089	$16.84M	0.9%	+1.4%	1.322%
5/15/2023	Cubist Systematic Strategies LLC	194,705	$1.72M	0.0%	-67.1%	0.135%
5/15/2023	Braidwell LP	648,451	$5.73M	0.2%	N/A	0.449%
5/15/2023	Bayesian Capital Management LP	12,270	$0.11M	0.0%	N/A	0.009%
5/15/2023	Gotham Asset Management LLC	46,283	$0.41M	0.0%	+46.2%	0.032%
5/15/2023	Two Sigma Advisers LP	15,900	$0.14M	0.0%	-55.5%	0.011%
5/15/2023	Two Sigma Investments LP	87,829	$0.78M	0.0%	-2.8%	0.061%
5/15/2023	Deutsche Bank AG	635,063	$5.61M	0.0%	+2.0%	0.440%
5/15/2023	Price T Rowe Associates Inc. MD	1,758,949	$15.53M	0.0%	-4.3%	1.219%
5/15/2023	Avalon Investment & Advisory	66,293	$0.59M	0.0%	-11.2%	0.046%
5/15/2023	Macquarie Group Ltd.	87,531	$0.77M	0.0%	+51.2%	0.061%
5/15/2023	XTX Topco Ltd	11,313	$100K	0.0%	N/A	0.008%
5/12/2023	Renaissance Technologies LLC	394,000	$3.48M	0.0%	-5.2%	0.273%
5/12/2023	Senator Investment Group LP	500,000	$4.42M	0.2%	-50.0%	0.346%
5/12/2023	Great West Life Assurance Co. Can	33,421	$0.30M	0.0%	-16.0%	0.023%
5/12/2023	BlackRock Inc.	11,768,441	$103.92M	0.0%	-4.9%	8.155%
5/12/2023	BNP Paribas Arbitrage SNC	65,502	$0.58M	0.0%	+65.6%	0.045%
5/12/2023	Bank of America Corp DE	445,175	$3.93M	0.0%	+215.0%	0.308%
5/12/2023	Prudential Financial Inc.	765,917	$6.76M	0.0%	+364.8%	0.531%

Data available starting January 2016

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer and autoimmune disorders. It offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Today's Range

Now: $5.07

$5.05

$5.29

50 Day Range

MA: $6.71

$5.07

$8.44

52 Week Range

Now: $5.07

$4.95

$10.79

Volume

1,259,386 shs

Average Volume

1,123,007 shs

Market Capitalization

$733.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of Adaptive Biotechnologies?: Adaptive Biotechnologies' top insider shareholders include:
Tycho Peterson (CFO)
Julie Rubinstein (President)
Nitin Sood (Insider)
R Mark Adams (COO)
Stacy L Taylor (SVP)
Kyle Piskel (Insider)
Michelle Renee Griffin (Director)
Chad M Cohen (CFO)
Chad M Robins (CEO)
Harlan S Robins (Insider)
Lance Baldo (Insider)
Learn More about top insider investors at Adaptive Biotechnologies.
Who are the major institutional investors of Adaptive Biotechnologies?: Adaptive Biotechnologies' top institutional investors include:
BlackRock Inc. — 7.94%
ARK Investment Management LLC — 7.24%
Sumitomo Mitsui Trust Holdings Inc. — 4.42%
Aristotle Atlantic Partners LLC — 2.15%
State Street Corp — 1.76%
Geode Capital Management LLC — 1.58%
Learn More about top institutional investors of Adaptive Biotechnologies stock.
Which major investors are selling Adaptive Biotechnologies stock?: Within the last quarter, ADPT stock was sold by these institutional investors:
Nuveen Asset Management LLC
BlackRock Inc.
JPMorgan Chase & Co.
Nordea Investment Management AB
Barclays PLC
Barclays PLC
Renaissance Technologies LLC
Versor Investments LP
Within the last year, company insiders that have sold Adaptive Biotechnologies company stock include:
Tycho Peterson (CFO)
Julie Rubinstein (President)
Nitin Sood (Insider)
R Mark Adams (COO)
Stacy L Taylor (SVP)
Kyle Piskel (Insider)
Michelle Renee Griffin (Director)
Learn More investors selling Adaptive Biotechnologies stock.
Which major investors are buying Adaptive Biotechnologies stock?: Within the previous quarter, ADPT stock was acquired by institutional investors including:
ARK Investment Management LLC
Aristotle Atlantic Partners LLC
Sumitomo Mitsui Trust Holdings Inc.
Goldman Sachs Group Inc.
Dimensional Fund Advisors LP
ExodusPoint Capital Management LP
Geode Capital Management LLC
Jefferies Financial Group Inc.